In cancer, lumican responds in a tissue-specific manner, both inhibiting cancer proliferation in melanoma [190,191] and pancreatic [192,193], breast [194–196] and prostate cancers [197] while inducing growth and metastasis in lung [198] and gastric cancers [199,200]. The gene discussed is LUM; the disease is cancer.